CIK: 1628992 - Address: 10170 Church Ranch Way, Suite 100, Westminster, CO 80021
9 results

TC

Stat

Stk

Ins

Fil

+d

+w

+m

+q

+h

+y

avg

S%ret11700-1-11-14-38-10
S%wins577143808010072

Filing Date

T Date

Ticker

Issuer

Inc

Sector

Ind

Industry

Owner

oSt

Rel

Title

T

TVal

Price

L

Qty

oc

Own

H

r2y

r1y

r6m

r3m

r6w

r3w

r7d

r3d

f1d

f1w

f1m

f3m

f6m

f1y

4/3/18 17:00
4/2/18
ABIOArca Biopharma, Inc.DEHealthDiagnIn Vitro & In Vivo DiagnosticSelby Brian L.COOVP,FinanS-10.49940-1-1000D
3/1/18 17:00
2/27/18
ABIOArca Biopharma, Inc.DEHealthDiagnIn Vitro & In Vivo DiagnosticSelby Brian L.COOVP,FinanS00.530000-131D
4/5/17 16:15
4/3/17
ABIOArca Biopharma, Inc.DEHealthDiagnIn Vitro & In Vivo DiagnosticSelby Brian L.COOVP,FinanS-32.460-1-471D-61-31-13-10-6-2-8-4405
3/1/17 17:12
2/27/17
ABIOArca Biopharma, Inc.DEHealthDiagnIn Vitro & In Vivo DiagnosticSelby Brian L.COOVP,FinanS.d02.5600-62D-48-26-116-4-2200-62
9/21/16 16:06
9/19/16
ABIOArca Biopharma, Inc.DEHealthDiagnIn Vitro & In Vivo DiagnosticSelby Brian L.COOVP,FinanS-12.9100-163D-68-53-22-2-53-2-220-13-19-15
4/6/16 17:00
4/4/16
ABIOArca Biopharma, Inc.DEHealthDiagnIn Vitro & In Vivo DiagnosticSelby Brian L.COOVP,FinanS-43.520-1-273D-73-44-33-24-3-4-220-215-14-22-32
3/2/16 16:31
2/29/16
ABIOArca Biopharma, Inc.DEHealthDiagnIn Vitro & In Vivo DiagnosticSelby Brian L.COOVP,FinanS-13.4600-44D-73-31-43-42-91-9-2-24-5-9-19-32
9/21/15 16:58
9/18/15
ABIOArca Biopharma, Inc.DEHealthDiagnIn Vitro & In Vivo DiagnosticSelby Brian L.COOVP,FinanS-36.2300-104D-36-319-3-113-6-32-14-16-22-40-53
3/2/15 16:47
3/2/15
ABIOArca Biopharma, Inc.DEHealthDiagnIn Vitro & In Vivo DiagnosticSelby Brian L.COOVP,FinanS-10.71100-1-333D-78-64-51-13-9-3-31-32161026-33

DDerivative transaction in filing (usually option exercise)
MMultiple transactions in filing; earliest reported transaction date and weighted average transaction price
AAmended filing
EError detected in filing
S - SaleSale of securities on an exchange or to another person
S - Sale+OESale of securities on an exchange or to another person (after option exercise)
F - TaxPayment of exercise price or tax liability using portion of securities received from the company
P - PurchasePurchase of securities on an exchange or from another person
Return to top

Contact